Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

AMGEN INC.

(AMGN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
CommuniquÚs de presse de la sociÚtÚ AMGEN INC.
12/01Amgen Announces Positive Top-Line Results From Otezla« (apremilast) Phase 3 DISCREET St..
PR
11/29AMGEN : Every Patient Counts, Every Story Matters
PU
11/29Amgen Named To Dow Jones Sustainability World Index For Eighth Consecutive Year
PR
11/24Amgen To Present At The 2021 Evercore ISI Healthcare Conference
PR
11/24Amgen To Present At The 2021 Piper Sandler Healthcare Conference
PR
11/23AMGEN : In a First for Industry, Murielle Veniant-Ellison Honored With 2022 Havel Lectures..
PU
11/22AMGEN : Supporting Access to Nutritious Foods in Amgen's Community
PU
11/17AMGEN : A New Way to Connect Psoriatic Disease Patients with Healthcare Providers
PU
11/17Amgen Awards The Bath Institute of Rheumatic Diseases $25,000 Through UPLIFT Innovation..
PR
11/16AMGEN : Leaders Join the Conversation at Financial Times Global Pharma and Biotech Confere..
PU
11/11COVID-19 Accelerates Biopharmaceutical Innovation, Bradway Says at Annual Investor Conf..
PU
11/10Amgen To Present At The 2021 Annual Cowen IO Summit
PR
11/09What to Know About Biologic Medicines for Severe Asthma
PU
11/08Successful Groundbreaking Ceremony for Amgen Ohio
PU
11/05Amgen Begins Construction On New Biomanufacturing Plant In Central Ohio
PR
11/05Amgen Featured in Video Series Highlighting Leading Innovators
PU
11/03AMGEN INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF ..
AQ
11/02AMGEN REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS - Form 8-K
PU
11/02AMGEN : Q3 Earnings Snapshot
AQ
10/28Amgen Announces Webcast Of 2021 Third Quarter Financial Results
PR
10/28Nina Parker on Breaking the Cycle of Asthma
PU
10/26Building Healthcare System Resilience With Biosimilars
PU
10/26Fortune and Great Place to Work« Name Amgen One of the World's Best Workplaces™ i..
PR
10/21AMGEN : Announces 2021 Fourth Quarter Dividend
PR
10/21AMGEN : Introducing Undruggable, a New Serial Podcast from Amgen R&D Exploring how Multisp..
PU
10/20AMGEN : A Special Edition of Innovation2, brought to you by David and Jim Reese (Brothers2..
PU
10/19AMGEN : Successfully Completes Acquisition Of Teneobio, Inc.
PR
10/19AMGEN : Named One of the ‘World's Best Workplaces'
PU
10/18AMGEN : Third-Longest Tenured Employee Leaves a Legacy After 35 Years of Service
PU
10/18AMGEN : “Green” Chemistry Makes Pharmaceutical Manufacturing Better for the Pl..
PU
10/11AMGEN : Working Together to Improve Public Health Outcomes
PU
10/08AMGEN : Discover What Fosters Innovation and Drives Change Through Amgen's Innovation2 Ser..
PU
10/07AMGEN : Announces New LUMAKRAS™ (sotorasib) Combination Data From Phase 1b CodeBreaK..
PR
10/07AMGEN : and Neumora Therapeutics Announce Strategic R&D Collaboration to Accelerate Novel ..
PR
10/04AMGEN : Presentation on Inflammation Portfolio from EADV
PU
10/01GLOBAL DIVERSITY AWARENESS MONTH : Our Differences Lead to Better Science
PU
09/29AMGEN : To Webcast Investor Call At EADV 2021
PR
09/28CANDID CONVERSATIONS : Amgen Latin Employee Network
PU
09/27AMGEN : Exploring Climate Change and Lung Health
PU
09/24AMGEN : FDA Approves Repatha« (evolocumab) In Pediatric Patients Age 10 And Older With Het..
PR
09/22AMGEN : To Present At The 2021 Cantor Global Healthcare Conference
PR
09/22AMGEN : Releases 8th Edition of Biosimilar Trends Report
PR
09/22AMGEN : Investor Presentation September 2021
PU
09/21AMGEN : Margaret Chu-Moyer Honored with Prestigious Portoghese Lectureship
PU
09/20AMGEN : Wins Patent Case on Otezla« (apremilast)
PR
09/20AMGEN : Joins International Respiratory Coalition as Founding Member
PU
09/17AMGEN : Celebrates 20 Years of Aranesp« (darbepoetin alfa) as a Treatment for Patients Wit..
PU
09/16AMGEN : Diversity, Inclusion and Belonging at Amgen – A Progress Report
PU
09/16AMGEN : Conference Call from ESMO Presentation
PU
09/16AMGEN : LUMAKRAS™ (Sotorasib) Combined With Vectibix« (Panitumumab) Showed Encouragi..
PR
09/14AMGEN : And The Lundquist Institute Announce That Diadem Therapeuctics Will Receive The Fi..
PR
09/13AMGEN : To Present At The 2021 Bank of America Merrill Lynch Global Healthcare Conference
PR
09/13AMGEN : To Webcast Investor Call At ESMO 2021
PR
09/10AMGEN : 20 Years Later and the Pain of 9/11 Still Feels Raw
PU
09/09AMGEN : to Present at the 19th Annual Morgan Stanley Global Healthcare Conference
PR
09/07AMGEN : Taking Time Off to Honor a Loved One (at Altitudes of 13,000 Feet)
PU
09/05AMGEN : New Tezepelumab Data Show 86% Reduction In Exacerbations In Patients With Severe A..
PR
09/03AMGEN : to Present at the 16th Annual Citi BioPharma Conference
PR
09/02AMGEN : Inside Amgen's “Virtual-First” Approach to Work
PU
08/27AMGEN : New Data At ESC Congress 2021 Shows Repatha« (evolocumab) Improves Features Of Pla..
PR
08/25AMGEN : Investor Presentation August 2021
PU
08/20AMGEN : Fellowship Program Between Amgen and Howard University Aims to Expand Talent Pool
PU
08/19AMGEN : Requires COVID-19 Vaccination for Staff in U.S. and Puerto Rico
PU
08/19AMGEN : Introducing DNA Unlocked, the First Podcast From Amgen R&D Exploring Human Genetic..
PU
08/19AMGEN : Has The Federal Circuit Just Put The Final Nail In The Coffin Of Broad Functional ..
AQ
08/09AMGEN INC : Entry into a Material Definitive Agreement, Financial Statements and Exhibits ..
AQ
08/04AMGEN : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATI..
AQ
08/03AMGEN : REPORTS SECOND QUARTER 2021 FINANCIAL RESULTS (Form 8-K)
PU
08/03AMGEN : Q2 Earnings Snapshot
AQ
08/03AMGEN : Announces Plans to Build Second New Manufacturing Facility in the U.S.
PU
07/30AMGEN : Announces 2021 Third Quarter Dividend
PR
07/30LUNG CANCER WON'T WAIT : Impact of the COVID-19 Pandemic on Lung Cancer Patients Globally ..
PU
07/30AMGEN : APPOINTS S. OMAR ISHRAK TO BOARD OF DIRECTORS (Form 8-K)
PU
07/30AMGEN INC : Change in Directors or Principal Officers, Financial Statements and Exhibits (..
AQ
07/29AMGEN : Federal Circuit Emphasizes High Bar For Enablement Of Functional Claims
AQ
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on AMGEN INC.